Works by Yuki Yoshikawa

Results: 60
    1

    Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report.

    Published in:
    2017
    By:
    • Takuya Tsujino;
    • Kiyoshi Takahara;
    • Tomohisa Matsunaga;
    • Yuki Yoshikawa;
    • Tomoaki Takai;
    • Taizo Uchimoto;
    • Kenkichi Saito;
    • Naoki Tanda;
    • Hajime Hirano;
    • Hayahito Nomi;
    • Naokazu Ibuki;
    • Teruo Inamoto;
    • Haruhito Azuma;
    • Tsujino, Takuya;
    • Takahara, Kiyoshi;
    • Matsunaga, Tomohisa;
    • Yoshikawa, Yuki;
    • Takai, Tomoaki;
    • Uchimoto, Taizo;
    • Saito, Kenkichi
    Publication type:
    journal article
    2
    3

    Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 507, doi. 10.1159/000515865
    By:
    • Ando, Yuwa;
    • Kawaoka, Tomokazu;
    • Amioka, Kei;
    • Naruto, Kensuke;
    • Ogawa, Yutaro;
    • Yoshikawa, Yuki;
    • Kikukawa, Chihiro;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Morio, Kei;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Yamauchi, Masami;
    • Tsuge, Masataka;
    • Hiramatsu, Akira;
    • Fukuhara, Takayuki;
    • Mori, Nami;
    • Takaki, Shintaro;
    • Tsuji, Keiji
    Publication type:
    Article
    4

    Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 491, doi. 10.1159/000515280
    By:
    • Naruto, Kensuke;
    • Kawaoka, Tomokazu;
    • Amioka, Kei;
    • Ogawa, Yutaro;
    • Chihiro, Kikukawa;
    • Yoshikawa, Yuki;
    • Ando, Yuwa;
    • Suehiro, Yosuke;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Kodama, Kenichiro;
    • Morio, Kei;
    • Fujino, Hatsue;
    • Murakami, Eisuke;
    • Nakahara, Takashi;
    • Yamauchi, Masami;
    • Tsuge, Masataka;
    • Hiramatsu, Akira;
    • Fukuhara, Takayuki;
    • Takaki, Shintaro
    Publication type:
    Article
    5

    Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.

    Published in:
    Oncology, 2021, v. 99, n. 5, p. 327, doi. 10.1159/000514315
    By:
    • Amioka, Kei;
    • Kawaoka, Tomokazu;
    • Ogawa, Yutaro;
    • Kikukawa, Chihiro;
    • Naruto, Kensuke;
    • Yoshikawa, Yuki;
    • Ando, Yuwa;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Morio, Kei;
    • Fujino, Hatsue;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Yamauchi, Masami;
    • Tsuge, Masataka;
    • Hiramatsu, Akira;
    • Imamura, Michio;
    • Fukuhara, Takayuki;
    • Mori, Nami;
    • Takaki, Shintaro
    Publication type:
    Article
    6
    7

    Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.

    Published in:
    Journal of Clinical Medicine, 2019, v. 8, n. 8, p. 1251, doi. 10.3390/jcm8081251
    By:
    • Komura, Kazumasa;
    • Fujiwara, Yuya;
    • Uchimoto, Taizo;
    • Saito, Kenkichi;
    • Tanda, Naoki;
    • Matsunaga, Tomohisa;
    • Ichihashi, Atsushi;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Yoshikawa, Yuki;
    • Nishimoto, Yudai;
    • Takai, Tomoaki;
    • Minami, Koichiro;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Ibuki, Naokazu;
    • Takahara, Kiyoshi
    Publication type:
    Article
    8
    9

    Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein.

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 151, doi. 10.1159/000513706
    By:
    • Yumi Kosaka;
    • Tomoki Kimura;
    • Tomokazu Kawaoka;
    • Yutaro Ogawa;
    • Kei Amioka;
    • Kensuke Naruto;
    • Yuki Yoshikawa;
    • Chihiro Kikukawa;
    • Yosuke Suehiro;
    • Kenji Yamaoka;
    • Yuwa Ando;
    • Shinsuke Uchikawa;
    • Kei Morio;
    • Takashi Nakahara;
    • Eisuke Murakami;
    • Shoichi Takahashi;
    • Masataka Tsuge;
    • Akira Hiramatsu;
    • Michio Imamura;
    • Keigo Chosa
    Publication type:
    Article
    10
    11
    12
    13

    Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer.

    Published in:
    Molecular Oncology, 2022, v. 16, n. 22, p. 3994, doi. 10.1002/1878-0261.13314
    By:
    • Yoshikawa, Yuki;
    • Stopsack, Konrad H.;
    • Wang, Xin Victoria;
    • Chen, Yu‐Hui;
    • Mazzu, Ying Z.;
    • Burton, Foster;
    • Chakraborty, Goutam;
    • Rajanala, Sai Harisha;
    • Hirani, Rahim;
    • Nandakumar, Subhiksha;
    • Lee, Gwo‐Shu Mary;
    • Frank, David;
    • Davicioni, Elai;
    • Liu, Glenn;
    • Carducci, Michael A.;
    • Azuma, Haruhito;
    • Kantoff, Philip W.;
    • Sweeney, Christopher J.
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.

    Published in:
    2022
    By:
    • Naruto, Kensuke;
    • Kawaoka, Tomokazu;
    • Kodama, Kenichiro;
    • Ogawa, Yutaro;
    • Amioka, Kei;
    • Yoshikawa, Yuki;
    • Kikukawa, Chihiro;
    • Suehiro, Yousuke;
    • Yamaoka, Kenji;
    • Ando, Yuwa;
    • Kosaka, Yumi;
    • Uchikawa, Shinsuke;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Ono, Atsushi;
    • Uchida, Takuro;
    • Yamauchi, Masami;
    • Okamoto, Wataru;
    • Takahashi, Shoichi;
    • Imamura, Michio
    Publication type:
    journal article
    21

    Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors.

    Published in:
    2022
    By:
    • Yoshikawa, Yuki;
    • Imamura, Michio;
    • Yamauchi, Masami;
    • Hayes, C. Nelson;
    • Aikata, Hiroshi;
    • Okamoto, Wataru;
    • Miyata, Yoshihiro;
    • Okada, Morihito;
    • Hattori, Noboru;
    • Sugiyama, Kazuhiko;
    • Yoshioka, Yukio;
    • Toratani, Shigeaki;
    • Takechi, Masaaki;
    • Ichinohe, Tatsuo;
    • Ueda, Tsutomu;
    • Takeno, Sachio;
    • Kobayashi, Tsuyoshi;
    • Ohdan, Hideki;
    • Teishima, Jun;
    • Hide, Michihiro
    Publication type:
    journal article
    22

    The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.

    Published in:
    Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01897-6
    By:
    • Komura, Kazumasa;
    • Hirosuna, Kensuke;
    • Tokushige, Satoshi;
    • Tsujino, Takuya;
    • Nishimura, Kazuki;
    • Ishida, Mitsuaki;
    • Hayashi, Takuo;
    • Ura, Ayako;
    • Ohno, Takaya;
    • Yamazaki, Shogo;
    • Nakamori, Keita;
    • Kinoshita, Shoko;
    • Maenosono, Ryoichi;
    • Ajiro, Masahiko;
    • Yoshikawa, Yuki;
    • Takai, Tomoaki;
    • Tsutsumi, Takeshi;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Takahara, Kiyoshi
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    Risk stratification for the prediction of overall survival could assist treatment decision‐making at diagnosis of castration‐resistant prostate cancer: a multicentre collaborative study in Japan.

    Published in:
    BJU International, 2021, v. 127, n. 2, p. 212, doi. 10.1111/bju.15187
    By:
    • Uchimoto, Taizo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Takahashi, Kazuhiro;
    • Fujiwara, Yuya;
    • Matsunaga, Tomohisa;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Maenosono, Ryoichi;
    • Yoshikawa, Yuki;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Ibuki, Naokazu;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Takahara, Kiyoshi;
    • Inamoto, Teruo;
    • Egawa, Shin
    Publication type:
    Article
    31
    32
    33

    Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer.

    Published in:
    Cancers, 2021, v. 13, n. 3, p. 526, doi. 10.3390/cancers13030526
    By:
    • Uchimoto, Taizo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Takahashi, Kazuhiro;
    • Nishimura, Kazuki;
    • Nakamori, Keita;
    • Fujiwara, Yuya;
    • Matsunaga, Tomohisa;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Maenosono, Ryoichi;
    • Yoshikawa, Yuki;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Ibuki, Naokazu;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Takahara, Kiyoshi
    Publication type:
    Article
    34
    35
    36

    Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.

    Published in:
    World Journal of Urology, 2023, v. 41, n. 12, p. 3585, doi. 10.1007/s00345-023-04687-3
    By:
    • Tsujino, Takuya;
    • Komura, Kazumasa;
    • Inamoto, Teruo;
    • Maenosono, Ryoichi;
    • Hashimoto, Takeshi;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Tokushige, Satoshi;
    • Ohno, Takaya;
    • Yamazaki, Shogo;
    • Fukushima, Tatsuo;
    • Nakamura, Ko;
    • Yano, Yusuke;
    • Nishimura, Kazuki;
    • Kinoshita, Shoko;
    • Nakamori, Keita;
    • Tsutsumi, Takeshi;
    • Matsunaga, Tomohisa;
    • Yoshikawa, Yuki;
    • Uchimoto, Taizo
    Publication type:
    Article
    37

    Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort.

    Published in:
    World Journal of Urology, 2020, v. 38, n. 12, p. 3183, doi. 10.1007/s00345-020-03118-x
    By:
    • Matsunaga, Tomohisa;
    • Komura, Kazumasa;
    • Hashimoto, Takeshi;
    • Muraoka, Ryu;
    • Satake, Naoya;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Yoshikawa, Yuki;
    • Takai, Tomoaki;
    • Minami, Koichiro;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Ibuki, Naokazu;
    • Takahara, Kiyoshi;
    • Inamoto, Teruo;
    • Ohno, Yoshio;
    • Azuma, Haruhito
    Publication type:
    Article
    38

    Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin.

    Published in:
    In Vivo, 2025, v. 39, n. 3, p. 1533, doi. 10.21873/invivo.13953
    By:
    • MAMORU HASHIMOTO;
    • KEN FUKIAGE;
    • KOSEI TANIGUCHI;
    • TAKAFUMI MINAMI;
    • TAKAFUMI YANAGISAWA;
    • WATARU FUKUOKAYA;
    • RYOICHI MAENOSONO;
    • YUKI YOSHIKAWA;
    • TAKUYA TSUJINO;
    • MASANOBU SARUTA;
    • KIYOSHI TAKAHARA;
    • YOSUKE HIRASAWA;
    • TAKESHI HASHIMOTO;
    • YOSHIO OHNO;
    • TAKAHIRO KIMURA;
    • RYOICHI SHIROKI;
    • KAZUTOSHI FUJITA
    Publication type:
    Article
    39

    Clinical Outcomes of Switching from Zoledronic Acid to Denosumab for the Management of Severe Bone Metastasis from Hepatocellular Carcinoma: A Single-Center, Open-Label, Prospective Intervention Trial.

    Published in:
    Yonago Acta Medica, 2023, v. 66, n. 4, p. 422, doi. 10.33160/yam.2023.11.007
    By:
    • Kensuke Naruto;
    • Tomokazu Kawaoka;
    • Shintaro Yamasaki;
    • Masanari Kosaka;
    • Yuki Shirane;
    • Yusuke Johira;
    • Shigeki Yano;
    • Kei Amioka;
    • Yutaro Ogawa;
    • Yuki Yoshikawa;
    • Kenji Yamaoka;
    • Shinsuke Uchikawa;
    • Hatsue Fujino;
    • Atsushi Ono;
    • Yasutomo Fujii;
    • Takashi Nakahara;
    • Eisuke Murakami;
    • Daiki Miki;
    • Masataka Tsuge;
    • Shiro Oka
    Publication type:
    Article
    40
    41
    42

    Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~.

    Published in:
    2021
    By:
    • Tsutsumi, Takeshi;
    • Komura, Kazumasa;
    • Hashimoto, Takeshi;
    • Muraoka, Ryu;
    • Satake, Naoya;
    • Matsunaga, Tomohisa;
    • Tsujino, Takuya;
    • Yoshikawa, Yuki;
    • Takai, Tomoaki;
    • Minami, Koichiro;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Ibuki, Naokazu;
    • Takahara, Kiyoshi;
    • Inamoto, Teruo;
    • Ohno, Yoshio;
    • Azuma, Haruhito
    Publication type:
    journal article
    43
    44

    Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 3, p. 539, doi. 10.1007/s10147-024-02676-z
    By:
    • Yamada, Yasutaka;
    • Sato, Kodai;
    • Sakamoto, Shinichi;
    • Tsujino, Takuya;
    • Saito, Sinpei;
    • Nishimura, Kazuki;
    • Fukushima, Tatsuo;
    • Nakamura, Ko;
    • Yoshikawa, Yuki;
    • Matsunaga, Tomohisa;
    • Maenosono, Ryoichi;
    • Kanesaka, Manato;
    • Arai, Takayuki;
    • Sazuka, Tomokazu;
    • Imamura, Yusuke;
    • Komura, Kazumasa;
    • Mikami, Kazuo;
    • Nakamura, Kazuyoshi;
    • Fukasawa, Satoshi;
    • Chiba, Kazuto
    Publication type:
    Article
    45

    Risk Classification for Overall Survival by the Neutrophil–Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab—A Multicenter Collaborative Study in Japan.

    Published in:
    Cancers, 2021, v. 13, n. 14, p. 3554, doi. 10.3390/cancers13143554
    By:
    • Uchimoto, Taizo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Kimura, Takahiro;
    • Takahashi, Kazuhiro;
    • Yano, Yusuke;
    • Nishimura, Kazuki;
    • Nakamori, Keita;
    • Fujiwara, Yuya;
    • Matsunaga, Tomohisa;
    • Tsutsumi, Takeshi;
    • Tsujino, Takuya;
    • Maenosono, Ryoichi;
    • Yoshikawa, Yuki;
    • Taniguchi, Kohei;
    • Tanaka, Tomohito;
    • Uehara, Hirofumi;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Takahara, Kiyoshi
    Publication type:
    Article
    46
    47
    48
    49

    Cyclin J–CDK complexes limit innate immune responses by reducing proinflammatory changes in macrophage metabolism.

    Published in:
    Science Signaling, 2022, v. 15, n. 729, p. 1, doi. 10.1126/scisignal.abm5011
    By:
    • Chong, Yee Kien;
    • Tartey, Sarang;
    • Yoshikawa, Yuki;
    • Imami, Koshi;
    • Li, Songling;
    • Yoshinaga, Masanori;
    • Hirabayashi, Ai;
    • Liu, Guohao;
    • Vandenbon, Alexis;
    • Hia, Fabian;
    • Uehata, Takuya;
    • Mino, Takashi;
    • Suzuki, Yutaka;
    • Noda, Takeshi;
    • Ferrandon, Dominique;
    • Standley, Daron M.;
    • Ishihama, Yasushi;
    • Takeuchi, Osamu
    Publication type:
    Article
    50

    The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 9, p. 2994, doi. 10.1245/s10434-019-07530-5
    By:
    • Komura, Kazumasa;
    • Hashimoto, Takeshi;
    • Tsujino, Takuya;
    • Muraoka, Ryu;
    • Tsutsumi, Takeshi;
    • Satake, Naoya;
    • Matsunaga, Tomohisa;
    • Yoshikawa, Yuki;
    • Takai, Tomoaki;
    • Minami, Koichiro;
    • Taniguchi, Kohei;
    • Uehara, Hirofumi;
    • Tanaka, Tomohito;
    • Hirano, Hajime;
    • Nomi, Hayahito;
    • Ibuki, Naokazu;
    • Takahara, Kiyoshi;
    • Inamoto, Teruo;
    • Ohno, Yoshio;
    • Azuma, Haruhito
    Publication type:
    Article